Literature DB >> 3295896

History of parkinsonism.

R Duvoisin.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3295896     DOI： 10.1016/0163-7258(87)90061-1

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  6 in total

1.  L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats.

Authors:  K Xu; D E Dluzen
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 2.  ABC of child abuse. Suffocation.

Authors:  R Meadow
Journal:  BMJ       Date:  1989-06-10

3.  L-dopa infusion mode differentially affects corpus striatal dopamine efflux in the presence of reserpine.

Authors:  D E Dluzen; F T Kratko
Journal:  J Neural Transm Gen Sect       Date:  1992

4.  Improved Bioavailability of Levodopa Using Floatable Spray-Coated Microcapsules for the Management of Parkinson's Disease.

Authors:  Jong-Suep Baek; Jie Kai Tee; Yi Yun Pang; Ern Yu Tan; Kah Leong Lim; Han Kiat Ho; Say Chye Joachim Loo
Journal:  Neuromolecular Med       Date:  2018-04-25       Impact factor: 3.843

5.  The effect of reserpine treatment in vivo upon L-dopa and amphetamine evoked dopamine and DOPAC efflux in vitro from the corpus striatum of male rats.

Authors:  D E Dluzen; B Liu
Journal:  J Neural Transm Gen Sect       Date:  1994

Review 6.  L-DOPA.

Authors:  Oleh Hornykiewicz
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.